CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Alefacept

Last Updated: November 16, 2004
Result type: Reports
Project Number: SR0024-000
Product Line: Reimbursement Review

Generic Name: Alefacept

Brand Name: Amevive

Manufacturer: Biogen Idec Canada Inc.

Therapeutic Area: Psoriasis, moderate to severe chronic plaque

Indications: Psoriasis, moderate to severe chronic plaque

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 26, 2005

Recommendation Type: Do not list